🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
This study is open to adults with diabetic macular edema that involves the ...
Status
Recruiting
Location
Associated Retina Consultants, Ltd.
Start Date
2026-05-14
Trial ID
NCT07553429
Treatments Being Tested
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This is a phase II open-label study evaluating the pharmacokinetics and pha...
Status
Withdrawn
Location
St. Boniface General Hospital Research Centre
Start Date
2020-01
Trial ID
NCT04025177
Treatments Being Tested
The overall aim of the study is to establish bioequivalence between commerc...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-05
Trial ID
NCT01599377
Treatments Being Tested
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
This trial is conducted in South Africa. The aim of this trial is to invest...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-03-20
Trial ID
NCT01486381
Treatments Being Tested
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested